Drugmakers to Benefit From Obama's Brain Initiative

Play

April 2 (Bloomberg) -- President Barack Obama announced a U.S. campaign that may lead to new treatments for some of the least understood brain disorders, benefiting efforts by Pfizer, Roche and Eli Lilly. Shannon Pettypiece reports on Bloomberg Television's "Money Moves." (Source: Bloomberg)